Both in Pharmaceuticals
Septerna vs Vera Therapeutics
Over the past year SEPN returned +94.5% and VERA returned +0.9%; their daily moves had a correlation of 0.23.
SEPN +94.5% VERA +0.9%Growth of $1, one year, split-adjusted
| Metric | SEPN | VERA |
|---|---|---|
| Price | $44.00 | $30.68 |
| Market cap | $2.05B | $2.21B |
| Today | −0.32% | +2.30% |
| 1 month | +12.4% | −5.2% |
| 6 months | +87.6% | −14.4% |
| Year to date | +57.8% | −39.4% |
| 1 year | +94.5% | +0.9% |
| Revenue growth (YoY) | +22375.6% | — |
| Gross margin | 100.0% | — |
| Net margin | −48.7% | — |
| P/E (TTM) | — | — |
| Price / sales | 20.8× | — |
| Net cash | $372.3M | $423.9M |
| Dividend yield | — | — |
| Volatility (60d) | 61.6% | 61.0% |
| Short % of float | 12.0% | 21.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).